Showing results (631-640 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|February 8, 2022
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseHong Zhang, Sami Z Daoud, Michael S Gillen, et al.Drugs in R&D|June 26, 2014
Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanismsNatasha Kozak, Joshua Friedman, Ami SchattnerDrugs in R&D|September 29, 2012
Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countriesGreg L PloskerDrugs in R&D|September 1, 2012
Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycinMary Kay Koenig, Adelaide A Hebert, Joan Roberson, et al.Drugs in R&D|August 3, 2012
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selectionKari R Nations, Roberta Bursi, Peter Dogterom, et al.Drugs in R&D|February 4, 2015
Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteersG L Wu, J Z Shentu, H L Zhou, et al.Drugs in R&D|November 12, 2022
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial ConditionsHong-Yu Luo, Hui-Zhi Long, Zi-Wei Zhou, et al.Drugs in R&D|November 15, 2024
Pharmacokinetics and Pharmacodynamics of Rusfertide, a Hepcidin Mimetic, Following Subcutaneous Administration of a Lyophilized Powder Formulation in Healthy VolunteersNishit B Modi, Sarita Khanna, Sneha Rudraraju, et al.Drugs in R&D|August 2, 2024
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic ImpairmentNicola Ferri, Sara De Martin, James Stuart, et al.Drugs in R&D|August 1, 2024
Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting ConditionsManuel Román, Dolores Ochoa, Samuel Martin, et al.Pageof 90